TERT and cancer: Moreover, patients in the T cohort showed significantly higher levels of circulating TERT mRNA also in the samples obtained close to the date of cancer diagnosis [T vs. NT cohort: 115 (0-421) copies/mL vs. 0 (0-206) copies/mL, p<0.001] (Table 2 and Figure 1B).